A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS

PHASE4CompletedINTERVENTIONAL
Enrollment

369

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

May 31, 2007

Conditions
Restless Legs Syndrome
Interventions
DRUG

Pramipexole

Trial Locations (49)

Unknown

248.615.45103 Boehringer Ingelheim Investigational Site, Kongens Lyngby

248.615.45102 Boehringer Ingelheim Investigational Site, København K

248.615.45101 Boehringer Ingelheim Investigational Site, København NV

248.615.45104 Boehringer Ingelheim Investigational Site, Vaerløse

248.615.35101 Boehringer Ingelheim Investigational Site, Espoo

248.615.35104 Boehringer Ingelheim Investigational Site, Joensuu

248.615.35103 Boehringer Ingelheim Investigational Site, Lahti

248.615.35102 Boehringer Ingelheim Investigational Site, Oulu

248.615.49109 Boehringer Ingelheim Investigational Site, Berlin

248.615.49105 Boehringer Ingelheim Investigational Site, Görlitz

248.615.49108 Boehringer Ingelheim Investigational Site, Hattingen

248.615.49106 Boehringer Ingelheim Investigational Site, München

248.615.49102 Boehringer Ingelheim Investigational Site, Schwerin

248.615.49103 Boehringer Ingelheim Investigational Site, Steglitz

248.615.49101 Boehringer Ingelheim Investigational Site, Ulm

248.615.49107 Boehringer Ingelheim Investigational Site, Witten

248.615.49104 Boehringer Ingelheim Investigational Site, Würzburg

248.615.35302, Birr

248.615.35301 Boehringer Ingelheim Investigational Site, Carrigtohill

248.615.35303, Castlecomer

248.615.39007 Policlinico di Bari - Università di Bari, Bari

248.615.39006 Ospedale Civile di Dolo, Dolo (VE)

248.615.39002 Ospedale S. Martino - A. O. Università di Genova, Genova

248.615.39008 Policlinico Gaetano Martino, Messina

248.615.39001 Istituto San Raffaele Turro, Milan

"248.615.39004 IRCCS Fondazione Istituto Neurologico C. Mondino", Pavia

248.615.39005 Ospedale S. Chiara, Pisa

248.615.39003 A. O. Santa Maria della Misericordia, Udine

248.615.47101 Boehringer Ingelheim Investigational Site, Bekkestua

248.615.47102 Boehringer Ingelheim Investigational Site, Fevik

248.615.47104 Boehringer Ingelheim Investigational Site, Moelv

248.615.47103 Boehringer Ingelheim Investigational Site, Oslo

248.615.47105 Boehringer Ingelheim Investigational Site, Tvedestrand

248.615.3408 Hospital Nuestra Señora de Sonsoles, Ávila

248.615.3402, Maderid

248.615.3404 Hospital General Universitario Gregorio Marañón, Madrid

248.615.3406, Madrid

248.615.3407, Madrid

248.615.3403 Hospital General de Catalunya, San Cugat Del Valles (Barcelona)

248.615.46101 Boehringer Ingelheim Investigational Site, Gothenburg

248.615.46103 Boehringer Ingelheim Investigational Site, Gothenburg

248.615.46102 Boehringer Ingelheim Investigational Site, Hedemora

248.615.46104 Boehringer Ingelheim Investigational Site, Örebro

248.615.44006 Boehringer Ingelheim Investigational Site, Buckshaw Village, Chorley

248.615.44004 Boehringer Ingelheim Investigational Site, Cambridge

248.615.44007 Boehringer Ingelheim Investigational Site, Manchester

248.615.44009 Boehringer Ingelheim Investigational Site, Reading

248.615.44002 Boehringer Ingelheim Investigational Site, Romford

248.615.44005 Boehringer Ingelheim Investigational Site, West Green, Crawley

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00349531 - A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS | Biotech Hunter | Biotech Hunter